Insulin resistance and β-cell dysfunction as therapeutic targets in type 2 diabetes

Authors



Dr Andrew Krentz, Consultant in Diabetes and Endocrinology, Southampton General Hospital, Southampton SO16 6YD, UK.
E-mail:
a.j.krentz@soton.ac.uk

Ancillary